Clinical Trials
2,229 trialsESME-MBC
UNICANCER
Oncoplastic Surgery Outcomes Database
Tufts Medical Center
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
Wake Forest University Health Sciences
QT-RIBRATING
CMC Ambroise Paré
PG2 BEAM-S
E-DA Hospital
HEROIC
Sun Yat-sen University
RUGCC-BC
Rutgers, The State University of New Jersey
NodeSMART
University Hospitals of Derby and Burton NHS Foundation Trust
Via Shalva
University Hospital, Basel, Switzerland
BCRL-SSR
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
ARTEMIS
Institut Cancerologie de l'Ouest
Multi-center MRD Registry for Inflammatory Breast Cancer
M.D. Anderson Cancer Center
Non-Contrast Breast MRI Diagnosis and Risk Stratification Using DWI-Generated Synthetic Contrast Enhancement
Peking University People's Hospital
LEARN
University of Sydney
Arm Exercise Capacity and Maximal Oxygen Consumption With Breast Cancer
Hacettepe University
MACRONAC
University Hospital, Basel, Switzerland
AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases
Asan Medical Center
Ultrasound Monitoring of Clipped Lymph Nodes to Predict Axillary Response After Chemotherapy in Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Stanford University
Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy
Memorial Sloan Kettering Cancer Center
OvAR-Y
Washington University School of Medicine
EXPRESSO
IRCCS San Raffaele
Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer
Mayo Clinic
A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
Beyond BCY
Jules Bordet Institute
Johns Hopkins Breast Cancer Program Longitudinal Repository
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mammo'C
University Hospital, Montpellier
Real-World Treatment of ADC-Resistant HER2-Low Advanced Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
C-BREAST-01
Gazi University
Core Biopsies for Establishing a Breast Tumor Tissue Repository
University of Southern California
HER2 CR
Nagoya City University
TAO
The Netherlands Cancer Institute
Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
THERapy
Fondazione Oncotech
Developing Breast (Cancer) Organoids
Maastricht Radiation Oncology
G-COR
The Cleveland Clinic
E-C-HAU
University Hospital, Lille
SRUS-Map
Anhui Provincial Cancer Hospital
Brain Health in Breast Cancer Survivors
Jonsson Comprehensive Cancer Center
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
LONGEVITI
University of Alberta
SHERLOCK
University Health Network, Toronto
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
CONCERT
University of Aberdeen
Molecular Subtyping of Breast Cancer-derived Small Extracellular Vesicles (sEVs) to Predict Therapeutic Efficacy
Fudan University
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum
University of Pittsburgh
Lymphedema Surveillance Study
Memorial Sloan Kettering Cancer Center
CDK and Body Composition Study
Montefiore Medical Center
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
Emory University